Pharmacy to Dose: The Critical Care Podcast

PCCs for PharmD Part II

Aug 30, 2022

01:15:57

Creator website

Highlights

AI Chapters

Episode notes

Is There Any Research Comparing Three Pact Factor Pc C With Four Pact C?

03:10

Hematoma Expansion Among Pc C Patients

02:23

I'm Hearing Four Packs of Platelets in the O R

03:33

Introduction

3min

What's the Deal With Colorado?

4min

Dosing Protocols for Tenna Inhibitors?

3min

Fixed Dosing Protocols

2min

Anticoagulation Reversal - Is There a Difference in Time to Administration?

3min

Is There Any Research Comparing Three Pact Factor Pc C With Four Pact C?

3min

Is There Any Data Comparing Our Four Factor Agents?

4min

Do You Need to Increase the Dose of Peba?

4min

The Biggest Pharmacist Study Ever

3min

10.

Aarand Cook and Morgan Jones, Both Friends of the Pod

3min

11.

Is There Any Evidence for Non-Reversal Indications?

4min

12.

I'm Hearing Four Packs of Platelets in the O R

4min

13.

Is There Any Evidence for the Use of Pc C's Verse and Dexa in Coagulation?

3min

14.

Is It a Panosis Study?

2min

15.

I'll Believe the Smaller Ones When They Match the Big Ones

2min

16.

Hematoma Expansion Among Pc C Patients

2min

17.

Do You Know What Happens if You Get Both?

4min

18.

Is There a Guideline on the Use of PCC or Indexina Alpha?

5min

19.

Reversal of Tennin Inhibitors

3min

20.

Tramadol - Is There a Study on the Horizon?

2min

21.

The Dosing Is Higher Than We've Ever Seen Before

2min

22.

Then I'll Be on the Lookout for the Results

2min

23.

I'll Give the Deck to Everybody, if There's a Red Wedding

5min

PCCs for PharmDs Part II

Special Guest: Scott Dietrich, PharmD, BCCCP

@PCC_PharmD

Reference List: https://pharmacytodose.files.wordpress.com/2022/08/pccs-for-pharmds-part-ii-references.pdf

04:45 – Fixed dose PCC; 11:58 – Time to administration; 15:00 – 3-factor v. 4-factor PCC; 19:12 – 4-factor PCC v. 4-factor aPCC; 30:36 – No anticoagulation reversal; 33:36 – PCC in surgery; 37:40 – PCC in trauma; 40:51 – PCC v. andexanet alfa; 54:10 – Guideline recommendations; 62:00 – Future studies; 69:10 – Take home points

PharmacyToDose.Com

@PharmacyToDose on Twitter

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.